High Compliance Rates With Patient-Reported Outcomes in Oncology Trials Submitted to the US Food and Drug Administration
- PMID: 30561701
- DOI: 10.1093/jnci/djy183
High Compliance Rates With Patient-Reported Outcomes in Oncology Trials Submitted to the US Food and Drug Administration
Comment on
-
Blinding and Patient-Reported Outcome Completion Rates in US Food and Drug Administration Cancer Trial Submissions, 2007-2017.J Natl Cancer Inst. 2019 May 1;111(5):459-464. doi: 10.1093/jnci/djy181. J Natl Cancer Inst. 2019. PMID: 30561711
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
